{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:59:34Z","timestamp":1776877174629,"version":"3.51.2"},"reference-count":30,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2026,2,15]]},"abstract":"<jats:p>Introduction: Prostate-specific antigen (PSA) can circulate bound to extracellular vesicles (EVs) and its measurement (ev-PSA) can be useful in prostate cancer. Although not designed with that purpose, total PSA assays react with ev-PSA. We evaluated the analytical performance of several total PSA assays in ev-PSA quantification and the impact of ev-PSA on total PSA measurement.\nMaterials and methods: Extracellular vesicles were isolated from 83 serum samples from prostate cancer patients by size exclusion chromatography or ultracentrifugation. PSA was quantified in serum, EVs, International Standard for PSA 17\/100 from the World Health Organization (WHO IS 17\/100) and exosomes from lymph node carcinoma of the prostate (LNCaP) cell line, using commercial immunoassays (Elecsys, Atellica, Immulite, Liaison and Kryptor).\nResults: Nanoparticle tracking analysis showed that the WHO IS 17\/100 contains significantly less EVs than serum (P &lt; 0.001). The sensitivity to detect ev-PSA followed this order: Elecsys ~ Atellica &gt; Immulite &gt; Liaison &gt; Kryptor. Ev-PSA could be detected in all serum samples with Elecsys and Atellica, but not with Immulite (87.8%), Liaison (58.5%) or Kryptor (48.8%). Bland-Altman analysis showed a proportional bias in ev-PSA quantification between Elecsys and other methods. Addition of ev-PSA to serum samples caused a proportional bias in PSA measurement between Elecsys and Immulite methods, with a relationship (r2 = 0.99; P &lt; 0.001) between ev-PSA and the difference in total PSA concentration between both methods.\nConclusions: While ev-PSA can be measured using commercial kits, notable differences exist between methods, which could lead to potential discrepancies in serum total PSA results across various assays.<\/jats:p>","DOI":"10.11613\/bm.2026.010703","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:30:43Z","timestamp":1765542643000},"page":"76-87","source":"Crossref","is-referenced-by-count":1,"title":["The analytical impact of extracellular vesicles PSA on different commercial total PSA measurement methods"],"prefix":"10.11613","volume":"36","author":[{"given":"Estibaliz","family":"Alegre","sequence":"first","affiliation":[{"name":"Service of Biochemistry, Cl\u00ednica Universidad de Navarra, Pamplona, Spain; Laboratory of circulating biomarkers in cancer, Cancer Center Cl\u00ednica Universidad de Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"P\u00e9rez Gracia","sequence":"additional","affiliation":[{"name":"Laboratory of circulating biomarkers in cancer, Cancer Center Cl\u00ednica Universidad de Navarra, Pamplona, Spain; Department of Oncology, Cl\u00ednica Universidad de Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Enrique","family":"Robles","sequence":"additional","affiliation":[{"name":"Department of Urology, Cl\u00ednica Universidad De Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ancizu-Marckert","sequence":"additional","affiliation":[{"name":"Department of Urology, Cl\u00ednica Universidad De Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Varo","sequence":"additional","affiliation":[{"name":"Service of Biochemistry, Cl\u00ednica Universidad de Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conxita","family":"Jacobs-Cacha","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain;  Clinical Biochemistry, drug delivery and therapy Research Group, Vall d\u2019Hebr\u00f3n Research Institute (VHIR), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roser","family":"Ferrer-Costa","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry Department, Vall d\u2019Hebron University Hospital, Barcelona, Spain;  Clinical Biochemistry, drug delivery and therapy Research Group, Vall d\u2019Hebr\u00f3n Research Institute (VHIR), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Sand\u00faa","sequence":"additional","affiliation":[{"name":"Service of Biochemistry, Cl\u00ednica Universidad de Navarra, Pamplona, Spain; Laboratory of circulating biomarkers in cancer, Cancer Center Cl\u00ednica Universidad de Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Moreno","sequence":"additional","affiliation":[{"name":"Service of Biochemistry, Cl\u00ednica Universidad de Navarra, Pamplona, Spain; Laboratory of circulating biomarkers in cancer, Cancer Center Cl\u00ednica Universidad de Navarra, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Service of Biochemistry, Cl\u00ednica Universidad de Navarra, Pamplona, Spain; Laboratory of circulating biomarkers in cancer, Cancer Center Cl\u00ednica Universidad de Navarra, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4885","published-online":{"date-parts":[[2026,2,15]]},"reference":[{"key":"key20251212123039_r1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20251212123039_r2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/clinchem\/hvab002","article-title":"Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice.","volume":"67","author":"Ferraro","year":"2021","journal-title":"Clin Chem"},{"key":"key20251212123039_r3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-8981(96)06437-6","article-title":"Individual prostate-specific antigen (PSA) forms as prostate tumor markers.","volume":"257","author":"Becker","year":"1997","journal-title":"Clin Chim Acta"},{"key":"key20251212123039_r4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000056523","article-title":"Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen.","volume":"20","author":"Stenman","year":"1999","journal-title":"Tumour Biol"},{"key":"key20251212123039_r5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/clinchem\/46.9.1310","article-title":"Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10).","volume":"46","author":"Rafferty","year":"2000","journal-title":"Clin Chem"},{"key":"key20251212123039_r6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/clinchem\/hvaa268","article-title":"Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions.","volume":"67","author":"Ferraro","year":"2021","journal-title":"Clin Chem"},{"key":"key20251212123039_r7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/clinchem\/hvae005","article-title":"Investigating the Current Harmonization Status of Tumor Markers Using Global External Quality Assessment Programs: A Feasibility Study.","volume":"70","author":"van Rossum","year":"2024","journal-title":"Clin Chem"},{"key":"key20251212123039_r8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1373\/clinchem.2005.059170","article-title":"Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update.","volume":"52","author":"Stephan","year":"2006","journal-title":"Clin Chem"},{"key":"key20251212123039_r9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10408363.2024.2309935","article-title":"Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories.","volume":"61","author":"Gonz\u00e1lez","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"key20251212123039_r10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5858\/arpa.2013-0134-OA","article-title":"Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma.","volume":"138","author":"Alegre","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"key20251212123039_r11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"key20251212123039_r12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"key20251212123039_r13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/14756366.2019.1697249","article-title":"Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH.","volume":"35","author":"Logozzi","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"key20251212123039_r14","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/ijc.29664","article-title":"Immuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer.","volume":"137","author":"Duijvesz","year":"2015","journal-title":"Int J Cancer"},{"key":"key20251212123039_r15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol"},{"key":"key20251212123039_r16","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"key20251212123039_r17","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1515\/cclm-2018-1297","article-title":"Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis.","volume":"57","author":"Mac\u00edas","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"key20251212123039_r18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2017.06.036","article-title":"Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients.","volume":"403","author":"Logozzi","year":"2017","journal-title":"Cancer Lett"},{"key":"key20251212123039_r19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117303","article-title":"PSA reactivity in extracellular microvesicles to commercial immunoassays.","volume":"543","author":"Sand\u00faa","year":"2023","journal-title":"Clin Chim Acta"},{"key":"key20251212123039_r20","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/cancers11101449","article-title":"Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study.","volume":"11","author":"Logozzi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"key20251212123039_r21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1515\/cclm-2022-0063","article-title":"Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes.","volume":"60","author":"Alegre","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"key20251212123039_r22"},{"key":"key20251212123039_r23","first-page":"439","article-title":"Recomendaciones para el estudio de la capacidad de detecci\u00f3n de los procedimientos de medida en el laboratorio cl\u00ednico.","volume":"23","author":"S\u00e1nchez Manrique","year":"2004","journal-title":"Qu\u00edmica Cl\u00ednica."},{"key":"key20251212123039_r24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/096228029900800204","article-title":"Measuring agreement in method comparison studies.","volume":"8","author":"Bland","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"key20251212123039_r25","first-page":"325","article-title":"Surface Proteome of Plasma Extracellular Vesicles as Biomarkers for Pneumonia and Acute Exacerbation of Chronic Obstructive Pulmonary Disease.","volume":"221","author":"Jung","year":"2020","journal-title":"J Infect Dis"},{"key":"key20251212123039_r26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1724600818754750","article-title":"Discordant prostate specific antigen test results despite WHO assay standardization.","volume":"33","author":"Boegemann","year":"2018","journal-title":"Int J Biol Markers"},{"key":"key20251212123039_r27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070047","article-title":"Regulation of the tumor suppressor PTEN through exosomes: a diagnostic potential for prostate cancer.","volume":"8","author":"Gabriel","year":"2013","journal-title":"PLoS One"},{"key":"key20251212123039_r28","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-13-0358","article-title":"Prostasomes: extracellular vesicles from the prostate.","volume":"147","author":"Aalberts","year":"2013","journal-title":"Reproduction"},{"key":"key20251212123039_r29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2018.07.043","article-title":"Biological variation estimates for prostate specific antigen from the European Biological Variation Study; consequences for diagnosis and monitoring of prostate cancer.","volume":"486","author":"Carobene","year":"2018","journal-title":"Clin Chim Acta"},{"key":"key20251212123039_r30","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.2147\/IJN.S283106","article-title":"Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis.","volume":"15","author":"Pang","year":"2020","journal-title":"Int J Nanomedicine"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/biochemia-medica.com\/en\/journal\/36\/1\/10.11613\/BM.2026.010703\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:45:50Z","timestamp":1771332350000},"score":1,"resource":{"primary":{"URL":"https:\/\/biochemia-medica.com\/en\/journal\/36\/1\/10.11613\/BM.2026.010703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,2,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2026.010703","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,15]]}}}